![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/00 | (2006.01) |
C07K 16/28 | (2006.01) | ||
C07K 16/30 | (2006.01) |
(11) | Number of the document | 2542256 |
(13) | Kind of document | T |
(96) | European patent application number | 11751204.6 |
Date of filing the European patent application | 2011-03-01 | |
(97) | Date of publication of the European application | 2013-01-09 |
(45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
(46) | Date of publication of the claims translation | 2019-10-25 |
(86) | Number | PCT/US2011/026689 |
Date | 2011-03-01 |
(87) | Number | WO 2011/109400 |
Date | 2011-09-09 |
(30) | Number | Date | Country code |
310692 P | 2010-03-04 | US | |
311057 P | 2010-03-05 | US | |
310695 P | 2010-03-04 | US |
(72) |
LOO, Deryk, T., US
HUANG, Ling, US
CHEN, Francine Zhifen, US
MOORE, Paul A., US
JOHNSON, Leslie S., US
|
(73) |
MacroGenics, Inc.,
9704 Medical Center Drive, Rockville, MD 20850,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Su B7-H3 reaguojantys antikūnai, jų imunologiškai aktyvūs fragmentai ir jų naudojimas |
ANTIBODIES REACTIVE WITH B7-H3, IMMUNOLOGICALLY ACTIVE FRAGMENTS THEREOF AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2025-02-10 | 15 | 289.00 EUR |
2026-03-01 |